Therefore, it is highly plausible that TRIM28 might be responsible for low steady-state level of XAF1 under physiological conditions and that its tumor-specific overexpression might be an alternative mechanism leading to XAF1 inactivation in cancer cells, particularly with no promoter hypermethylation. This evidence concerns the gene XAF1 and cancer.